SCHEMBL16410601

SCHEMBL16410601

[N-]=[N+]=NCc1ccc(CNNC2=Nc3ccccc3NC23CCN(N)CC3)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410616 0.88 ACAT2 (0.39) —
SCHEMBL16410538 0.83 KMT2A (0.32) —
SCHEMBL16410628 0.81 — —
SCHEMBL16410633 0.81 ACAT2 (0.37) —
SCHEMBL16410786 0.80 — —
SCHEMBL16410697 0.77 — —
SCHEMBL16410666 0.77 — —
SCHEMBL16410751 0.75 — —
SCHEMBL16410634 0.75 CXCR4 (0.34) —
SCHEMBL16410622 0.75 KMT2A (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback